AuditCompensationNominating and Corporate GovernanceScientific
John C. Martin, PhD 
John C. Martin, PhD
Executive Chairman, Gilead Sciences


Dr. Martin joined Gilead Sciences in 1990 and was appointed Executive Chairman in March 2016. He served as Chairman and Chief Executive Officer from June 2008 through March 2016 and President and Chief Executive Officer from 1996 through May 2008. Prior to joining Gilead, Dr. Martin held several leadership positions at Bristol-Myers Squibb and Syntex Corporation.

Dr. Martin previously served as President of the International Society for Antiviral Research, Chairman of the Board of Dir... 
    
John F. Cogan, PhD  Lead Director
John F. Cogan, PhD
Lead Independent Director, Gilead Sciences


John F. Cogan, PhD joined Gilead’s Board of Directors in July 2005 and was appointed Lead Independent Director in May 2013. Dr. Cogan is currently the Leonard and Shirley Ely Senior Fellow at the Hoover Institution and a Professor in the Public Policy Program at Stanford University, where he has had a continuing appointment since 1980. Dr. Cogan’s current research is focused on U.S. budget and fiscal policy, social security and health care. Dr. Cogan has held a number of positions in the U.S.... 

Committee Member    Committee Member
Kelly A. Kramer Financial Expert
Kelly A. Kramer
Executive Vice President and Chief Financial Officer, Cisco Systems, Inc.


Kelly A. Kramer joined Gilead’s Board of Directors in August 2016. Ms. Kramer is currently Executive Vice President and Chief Financial Officer of Cisco Systems, Inc. Prior to that she was Senior Vice President of Corporate Finance at Cisco. She previously served as Vice President and Chief Financial Officer of GE Healthcare Systems and Chief Financial Officer of GE Healthcare Biosciences. Ms. Kramer has also worked in GE’s Corporate Headquarters, Transportation Systems and Aerospace division... 

Committee Member    
Kevin E. Lofton, FACHE 
Kevin E. Lofton, FACHE
Chief Executive Officer, Catholic Health Initiatives


Kevin E. Lofton joined Gilead’s Board in July 2009. He is currently the Chief Executive Officer of Catholic Health Initiatives. Headquartered in Denver, the healthcare system has revenues of over $13 billion and operates the full continuum of services from hospitals to home health agencies throughout the nation. He previously served as Chief Executive Officer of two university hospitals, the University of Alabama at Birmingham Hospital and Howard University Hospital in Washington, D.C. In 200... 

Committee Member Committee Member   
John W. Madigan Financial Expert
John W. Madigan
Retired Chairman and Chief Executive Officer, Tribune Company


John W. Madigan joined our Board in 2005. He is the retired Chairman and Chief Executive Officer of Tribune Company, a director and former Chairman of the Robert R. McCormick Foundation and a director of Boise Cascade Holdings, L.L.C. Mr. Madigan is also a former member of the Defense Business Board of the Department of Defense, an advisor to Madison Dearborn Partners and a director and former Chairman of The Chicago Council on Global Affairs. He previously served as a director of AT&T Wirele... 

Committee Member Chairperson   
John F. Milligan, PhD 
Biography PhotoJohn F. Milligan, PhD
President and Chief Executive Officer, Gilead Sciences


Dr. Milligan joined Gilead Sciences in 1990 and was appointed Chief Executive Officer in March 2016. He was appointed President in 2008, and from 2007 to 2016 served in the role of Chief Operating Officer as well. He previously held multiple leadership roles within Gilead, including the position of Chief Financial Officer from 2002 to 2007.

Dr. Milligan was named "Bay Area CFO of the Year" in 2006 for companies with revenues greater than $500 million, and he was named the top b... 

    
Nicholas G. Moore Financial Expert
Nicholas G. Moore
Retired Global Chairman, PricewaterhouseCoopers


Nicholas G. Moore joined Gilead’s Board of Directors in March 2004. Mr. Moore is the retired global Chairman of PricewaterhouseCoopers LLP, a professional services firm formed in July 1998 by the merger of Coopers & Lybrand and Price Waterhouse. Prior to the merger, Mr. Moore was elected Chairman and Chief Executive Officer of Coopers & Lybrand (U.S.) in 1994 and Coopers & Lybrand International in 1997. Mr. Moore is the lead independent director of NetApp and a director of Bechtel Group, Inc.... 

Chairperson Committee Member   
Richard J. Whitley, MD 
Richard J. Whitley, MD
Distinguished Professor, Loeb Scholar Chair in Pediatrics, Professor of Pediatrics, Microbiology, Medicine, and Neurosurgery, University of Alabama at Birmingham


Dr. Whitley joined Gilead's Board of Directors in 2008. He is a Distinguished Professor, Loeb Scholar Chair in Pediatrics; Director, Division of Pediatric Infectious Diseases; Vice-Chair, Department of Pediatrics; Senior Scientist, Department of Gene Therapy; Senior Scientist, Cancer Research and Training Center; Associate Director for Clinical Studies, Center for AIDS Research; and Co-Director, Center for Emerging Infections and Emergency Preparedness (CEIEP) for the institution.

Dr.... 

   Committee Member Chairperson
Gayle Edlund Wilson 
Gayle Edlund Wilson
Chairman Emeritus of COSMOS, The California State Summer School for Math and Science


Gayle Edlund Wilson joined Gilead’s Board of Directors in October 2001. Mrs. Wilson served as California’s First Lady from 1991 to 1999. Mrs. Wilson is a member of the board of directors of the Ralph M. Parsons Foundation, a non-profit organization that provides grants for higher education, social impact, civic, cultural issues and health issues. She is also the Chair Emeritus of the Advisory Board of the California State Summer School for Math and Science, a member of the board of trustees o... 

   Chairperson Committee Member
Per Wold-Olsen 
Per Wold-Olsen
Retired President,
Human Health Intercontinental Division, Merck & Co., Inc.


Mr. Wold-Olsen joined Gilead’s Board of Directors in January 2010 after serving as the Chair of the company’s Health Policy Advisory Board since 2007. From 2005 to 2006, Mr. Wold-Olsen served as President of the Human Health Intercontinental Division of Merck & Co., Inc., a leading global pharmaceutical company. From 1997 until 2005, he served as President of Human Health Europe, Middle East/Africa and Worldwide Human Health Marketing for Merck & Co.,Inc. Mr. Wold-Olsen is currently Chairman ... 

  Committee Member Committee Member Committee Member
  • Member
  • Chairperson
  • Financial Expert

   Mr. Cogan is the Lead Independent Director.